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COMMUNICATION 
Exploiting Azinium-π Interactions in Structure-guided Discovery
of Inhibitors against Fungal Glucan-remodelling Enzymes.  
Ignacio Delso,*[a] Jessika Valero-Gonzalez,[b] Fernando Gomollón-Bel,[a] Jorge Castro-López,[b] Wenxia 
Fang,[c]  Iva Navratilova,[c] Daan M.F. van Aalten,[c]  Tomás Tejero,[a] Pedro Merino,*[b] and Ramon 
Hurtado-Guerrero*[b,d] 
Abstract: Fungal -1,3-glucan glucanosyltransferases are glucan-
remodeling enzymes with key roles in cell wall integrity, and are 
essential for the viability of pathogenic fungi/yeasts. They are 
considered drug targets, although inhibitors have not yet been 
reported. Here, we report a multidisciplinary approach leading to the 
discovery of laminaritriose units-composed glycomimetics with high 
affinity for Saccharomyces cerevisiae Gas2 and Aspergillus
fumigatus Gel4. We also demonstrate by X-ray crystallography that 
the compounds bind in the active site of Gas2 and interact with the 
catalytic machinery. Topological analysis of non-covalent 
interactions demonstrate that the combination of a triazole with 
positively charged aromatic moieties are important for optimal 
interactions through unusual pyridinium cation-π and face-to-face 
ππ interactions. The lead compound 12 inhibits AfGel4 with an IC50 
value of 42 M, validating our rational approach for the design of 
glycomimetics for these enzymes.  
The fungal cell wall is essential for the integrity of the cell, 
providing strength, shape and protection against environmental 
insults.[1] However, rather than being a rigid structure it has 
inherent plasticity during cell growth and adaptation to the 
environment.[2] Cell wall remodelling enzymes and in particular 
the large family of -1,3-glucan glucanosyltransferases or 
transglycosylases (TGs) contribute to this plasticity.[3] These 
enzymes remodel the polysaccharide -1,3-glucan, which is the 
major component of the fungal cell wall. They  cleave   the  β-1,3 
bond  of   β-1,3-glucan oligosaccharides with at least 10 glucose 
units and transfer the newly formed reducing end (>5 glucose 
units)   to   the   nonreducing   end   of   another   β-1,3-glucan 
oligosaccharide,  resulting  in  the  elongation  of  the  β-1,3-glucan.[4] 
These TGs have been found in all fungal species investigated to 
date and are named differently depending on the fungi or yeasts 
in which they are found (e.g. Gelp, Gasp and Phrp in A.
fumigatus, S. cerevisiae and C. albicans, respectively).[5] In 
yeasts, these TGs have important roles in spore and hyphal wall 
assembly, and maintaining cell wall integrity during vegetative 
growth, and are essential for viability of Schizosaccharomyces
pombe.[6] In fungi, the gene encoding the TG Gel4 in A.
fumigatus is also essential for viability.[4] This family of TGs is 
grouped into 3 subfamilies based on the presence or absence of 
CBM43, a carbohydrate binding module most commonly 
associated   with   β(1-3)glucan binding activity and a 
serine/threonine-rich region that contains O-glycosylation 
putative sites.[4,7] We previously reported the crystal structure of 
ScGas2 in complex with laminarioligossacharides[7] and recently 
trapped a covalent intermediate on the pathway to 
transglycoslation (Figure 1).[8] From these structures, we defined 
the different sites for the sugar moieties bound in the donor and 
acceptor sites, and we also verified the role of the proposed 
acid-base Glu176 and the nucleophile Glu275.  
Figure 1. View of the active site of the covalent intermediate of  E176Q 
ScGas2 with laminaritetraose (donor site) in complex with laminaripentaose  
(acceptor site; see PDB ID: 5FIH [ref]). The carbons of the oligosaccharides 
located at the donor and acceptor sites are shown as yellow sticks. The 
compound 1 (carbons shown as cyan sticks) docked in ScGas2 active site is 
superposed with the above structure. Residues as grey sticks are involved in 
interactions with the sugar moieties and compound 1. Note that
laminaritetraose is covalently bound to E275.  
Although these enzymes are potential antifungal drug targets, 
there are currently no potent inhibitors of this family of enzymes. 
We previously synthetized[9] and characterised compound 1, a 
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laminaritriose derivative bound to a phenyl moiety through a 
flexible linker, which showed a poor affinity (Kd = 800 ± 100 µM) 
towards Gas2 (Figure 1). We used ScGas2 for our studies here 
because it is a homologue of AfGel4, a proposed antifungal drug 
target [ref], and its crystal structure has been reported [ref]. 
ScGas2 is similar to AfGel4 at the sequence level (ca. 50% 
sequence identity in the catalytic domains, and 100% if 
considering all the key residues recognising carbohydrates from 
-3 to +1; see Figure S1).[7] The rationale for making compound 1 
was to occupy the donor site with the sugar moieties by 
interacting with the conserved Pro136 and Tyr107, and reach 
the acceptor site establishing CH-pi interactions between the 
phenyl moiety and the conserved Tyr244, as exemplified by a 
docked model of compound 1 in the ScGas2 active site (Figure 
1). In this model, the trisaccharide moiety occupies the -2 to -4 
subsites and two conserved tyrosine residues (Tyr107 and 
Tyr244) interact with the first [you mean -1?] sugar unit 
(carbohydrate-π interactions)[10] and the phenyl group of at the 
ligand tail (CH-π interactions) [11]. Taking advantage of the high 
structural homology and the complete conservation of the active 
site among AfGel4 and ScGas2, we reasoned that the 
introduction of an additional aromatic moiety interacting an 
additional conserved tyrosine (Tyr307, Figure 1) could result in 
an enhanced binding for both AfGel4 and ScGas2. 
Simultaneously, it should also be possible to explore different 
aromatic residues at the ligand tail to enhance interactions with 
Tyr244.  
In this study, we explore the use of a triazole scaffold to 
reach Tyr307 taking advantage of two amenable and efficient 
synthetic strategies based on click chemistry.[12] We 
demonstrate the strength of this strategy by synthesizing eleven 
different candidates and determining their dissociation constants 
(Kds) towards ScGas2 and AfGel4. The results demonstrate that 
the laminaritriose moiety directly bound to a triazole together 
with positively charged aromatic moieties at ligand tail are 
important for an optimal interaction with these enzymes. The 
observed results are confirmed by solving the crystal structures 
of ScGas2 in complex with 7 out of the 11 compounds by X-ray 
crystallography studies in combination with computational NCI 
analyses. These data also show that hydrophobic interactions, 
particularly π-π and azinium-π (cation-π) interactions, between 
Tyr244 and the aromatic moieties at the ligand tail, as well as 
between the triazole moiety and Tyr307, are the determinants of 
the increased affinity for ScGas2.  
Introduction of the triazole ring into the linker was achieved 
through the well-known CuAAC reaction applied to carbohydrate 
chemistry.[13] Two alternative coupling strategies for preparing 
the triazole ring were explored, i.e.: laminarioligosaccharide 
alkyne with a properly substituted azide and 
laminarioligosaccharide azides[14] with properly substituted 
alkynes (Figure 2). Compound 2, an analogue of compound 1 
containing a triazole ring in the linker, was prepared following 
the first strategy (Figure 2). However, docking studies with 2 
(Glide, see SI) showed that the triazole ring did not reach the 
target Tyr307. In fact, with ScGas2 we obtained a value of Kd = 
17.0 ± 0.1 µM for 2 (Table 1, entry 2), higher than the Kd for the 
equivalent compound 6, which differed in the position of the 
triazole (Kd = 6.2 ± 0.1 µM; see below for its synthesis). 
 
Figure 2. Chemical synthesis of ligands through typical click-chemistry. 
Docking studies suggested that a triazole positioned closer 
to the sugar units as well as electron-poor aromatic residues at 
the ligand tail would increase the affinity of the ligand (See SI). 
Consequently, we prepared compounds 3-12 following the 
strategy illustrated in Figure 2. In order to evaluate the effect in 
binding of the carbohydrate units we also prepared mono- (3-4) 
and disaccharides (5) in addition to potential ligands bearing a 
trisaccharide unit. Monosaccharides 3-4 and disaccharide 5 
showed high Kd values (Table 1), reinforcing our finding that 
three units of trisaccharide are required as a minimum 
recognition scaffold. Aromatic residues in compounds 6 and 7 
(Table 1) lowered the Kd values for ScGas2, similar values being 
observed for AfGel4 in line with a high identity between enzymes. 
Increasing of the size ring from phenyl (6) to naphthyl (7) did not 
improve binding affinity. Employing an electron withdrawing 
substituent (Table 1) on the aromatic ring we observed an 
intermediate value and with the thienyl-derivative 9 (entry 9), we 
obtained one of the lowest Kd values observed for both ScGas2 
and AfGel4. In searching for stronger π-π interactions by 
introducing π-deficient aromatic rings which can interact in a 
more efficient way[15] with the electron rich aromatic ring of 
tyrosine, we moved to the pyridine derivative 10 which, at 
physiological pKa is amenable to be protonated to some extent 
as demonstrated by NMR experiments (see SI). Moderate Kd 
values were obtained for both enzymes (Table 1). Using 
positively charged pyridinium moiety as in 11 (Table 1, entry 11) 
reduced the Kd, particularly for AfGel4, which was further 
enhanced when we moved from pyridinium 11 to quinolinium 
derivative 12 (Table 1, entry 12). Compound 12 showed Kd = 
3.10 ± 0.02 and 1.50 ± 0.01 µM, against ScGas2 and AfGel4, 
respectively, being the lowest found among all the prepared 
glycomimetics. Figure 3 illustrates determination of the Kd for 
compound 12 towards ScGas2 by SPR. In addition, we could 
not obtain a Kd for laminaritriose due to its low affinity (Table 1, 
entry 13). This result points to the introduced groups (triazole 
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ring and aromatic residues) as the responsible of the tight 
binding of the designed glycomimetics to both enzymes. 
Table 1. Dissociation constants of compounds 1-12 for ScGas2 and AfGel4. 
entry Compound Kd (ScGas2) (M) Kd (AfGel4)  (M)  
1 1[a] 800 ± 100 nd[b] 
2 2 17 ± 0.1 nd 
3 3 171 ± 1 nd 
4 4 72 ± 1 nd 
5 5 68 ± 1 nd 
6 6 6.2 ± 0.1 6.00 ± 0.06 
7 7 13.00 ± 0.01 10.0 ± 0.1 
8 8 9.80 ± 0.07 nd 
9 9 4.09 ± 0.04 3.60 ± 0.03 
10 10 8.06 ± 0.07 5.30 ± 0.06 
11 11 4.60 ± 0.03 2.50 ± 0.02 
12 12 3.10 ± 0.02 1.50  ± 0.01 
13 laminaritriose [c] nd 
[a] = determined by tryptophan fluorescence spectroscopy; [b] nd = not 
determined; [c] = too weak to measure 
 
Figure 3. Surface plasmon resonance (SPR) measurements for compound 12 
towards ScGas2. The various concentrations of 12 show the binding reaction 
and the calculated dissociation constant is 3.1 ± 0.02 μM. Plain brown lines 
show the fitted curve of non-linear regression. 
To elucidate the binding mode of the designed 
glycomimetics we solved the crystal structures of compounds 6-
12 in complex with ScGas2 at high resolution, ranging from 1.4 
to 2.15 Å (Figure 4, SI). In all cases, the trisaccharide unit 
occupied the donor site in the -2, -3 and -4 positions. The 
triazole ring was observed to form - stacking interactions with 
Y307. The observed interactions of the aromatic residue located 
at the ligand tail were different depending on the ring type. Thus, 
whereas ligands 6-9 adopt a T-shape (edge-to-face) orientation 
of the aromatic residues with respect to Tyr244, positively 
charged residues in 11 and 12 adopt a parallel orientation. The 
case of pyridine derivative 10 deserves a more detailed 
discussion. 
 
Figure 4. X-ray structures of ScGas2 in complex with 6 (A), 7 (B), 8 (C), 9 (D), 
10 (E), 11 (F) and 12 (G). The unbiased (i.e. before inclusion of any ligand 
model) |Fo |- |Fc |, calc electron density maps are shown at 2.2 .  
In addition, for compounds 6, 8 and 9, another ligand 
molecule is observed at the acceptor site, likely due to the less 
optimal interactions between the radical at the tail position with 
Y244 (see Figure S2). The observed T-shape orientation 
observed for compounds 6-9 corresponds to a typical CH-π  
interaction, as that observed in the docked structure of 1. In the 
case of compound 10, two conformations were found in the X-
ray structure (Figure 4, E). One conformation corresponds to the 
neutral  ligand  folded  on  itself  and  stabilized  by  intramolecular  π-
π  interactions  with  the  thiazole  ring  and  H-bonding with a water 
molecule, which is also interacting with E176 and E275. Notably, 
the other conformation corresponds to a protonated pyridine ring, 
which adopts a parallel orientation with respect to Tyr244. This 
favours a transfer of charge between the Tyr244 electron-rich 
aromatic ring and the electron-poor pyridinium ring through 
pyridinium−π   (cation−π)   interaction, which has been shown to 
be stronger than the typical face-to-face π−π interactions,[16] 
rarely observed in protein structures where most of the 
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orientations are T-shaped (also named as edge-to-face).[17] To 
evaluate the conformational preferences, we carried out a 
molecular dynamics (MD) study of ScGas2 in complex with 
compound 10 in folded/unfolded and protonated/neutral states. 
MD calculations (Figure 5) showed that both protonated and 
neutral folded derivatives become unfolded after 0.6 and 2.5 ns, 
respectively. This result suggests that the unfolded conformation 
is the most representative.  
 
Figure 5. Molecular dynamics of 10 showing unfolding after 2.5 ns and its 
maintenance up to 30 ns. Starting structures: red trace: protonated folded; 
green trace: neutral folded; black trace: protonated unfolded; blue trace: 
neutral unfolded 
The results observed with compound 10 indicate that the 
presence of a positively charged π-deficient aromatic residue 
induces a change of the relative orientation between the 
aromatic residue and Tyr244. Indeed, when the positive charge 
is permanent (at physiological pH) as in the case of aziniums 11 
and 12, only unfolded conformations with a parallel orientation to 
Tyr244 are found in the X-ray structure. The parallel orientation 
allows  more  efficient  π,π-interactions with Tyr244 in comparison 
with CH-π interactions observed in compounds 6-9. The 
existence of these interactions was confirmed through a 
topological NCI analysis[18] that showed the expected surfaces 
for such a sort of non-covalent interactions (Figure 6).  
 
Figure 6. NCI analysis showing characteristic surfaces for T-shape (left, 
compound 7) and parallel (right, compound 12) oriented ligands corresponding 
to CH-π and azinium-π  (cation-π)  interactions,  respectively.   
As a final verification of our approach, we conducted 
inhibition studies of the best ligand 12 on AfGel4.[19] The 
experiments indicated that this compound was capable of 
inhibiting AfGel4 with an IC50 value of 42.0 M (See SI), 
validating our approach of using ScGas2 as a model for the 
design of glycomimetics against AfGel4. 
In summary, after a rational design of ligands for AfGel4 
using ScGas2 as a model, we have obtained quinolinium 
derivative 12 showing a Kd of 1.50 ± 0.01 µM and inhibitory 
properties against AfGel4 (IC50 = 42 µM).  During the design, 
π,π-interactions with Tyr307 and Tyr244 were discovered to be 
the driving force for achieving optimal binding. In particular, in 
the case of Tyr244, interactions with positively charged aromatic 
residues favours a parallel orientation of the aromatic rings, 
which enhances the strength of the resulting azinium-π (cation-
π) interactions. Understanding the ultimate conditions to design 
a good ligand for ScGas2 we obtained a first low micromolar 
inhibitor for AfGel4 demonstrating the validity of the approach. 
These studies will open the door to the design of more potent 
inhibitors of AfGel4 that could be useful as a platform to discover 
antifungal therapeutic agents.  
Acknowledgements  
This work was supported by Spanish MINECO Contracts 
(CTQ2016-76155-R to P.M., and BFU2016-75633-P to R.H-G.), 
and an MRC Programme Grant (M004139) to D.M.F.v.A. We 
also acknowledge the Government of Aragón (Spain) 
(Bioorganic Chemistry group E-10 and Protein Targets group B-
89) for financial support. We acknowledge the Institute of 
Biocomputation and Physics of Complex Systems (BIFI) at the 
University of Zaragoza (Spain) for computer time at clusters 
Terminus and Memento. We thank synchrotron radiation 
sources DLS (Oxford), and in particular beamline I02 
(experiment number MX10121-11), and ALBA (Barcelona), and 
in particular XALOC beamline. European Commission is 
gratefully acknowledged (BioStruct-X grant agreement 
N°283570 and BIOSTRUCTX_5186). 
Keywords: transglycosylases •  Aspergillus fumigatus •  
oligosaccharides •  glycomimetics •  carbohydrates 
 [1] I. V. Ene, L. A. Walker, M. Schiavone, K. K. Lee, H. Martin-Yken, E. 
Dague, N. A. Gow, C. A. Munro, A. J. Brown, mBio 2015, 6, e00986. 
[2] J. P. Latge, Mol. Microbiol. 2007, 66, 279-290. 
[3] (a) I. Mouyna, L. Hartl, J. P. Latge, Frontiers in microbiology 2013, 4, 81. 
(b) E. Cabib, J. Arroyo, Nat. Rev. Microbiol. 2013, 11, 648-655. 
[4] A. Gastebois, T. Fontaine, J. P. Latge, I. Mouyna, Eukaryot. Cell 2010, 
9, 1294-1298. 
[5] (a) F. Sillo, C. Gissi, D. Chignoli, E. Ragni, L. Popolo, R. Balestrini, 
Fungal Genet. Biol. 2013, 53, 10-21. (b) W. Zhao, C. Li, J. Liang, S. 
Sun, Glycobiology 2014, 24, 418-427. 
[6] (a) E. Ragni, A. Coluccio, E. Rolli, J. M. Rodriguez-Pena, G. Colasante, 
J. Arroyo, A. M. Neiman, L. Popolo, Eukaryot. Cell 2007, 6, 302-316. 
(b) E. Ragni, J. Calderon, U. Fascio, M. Sipiczki, W. A. Fonzi, L. Popolo, 
Fungal Genet. Biol. 2011, 48, 793-805. (c) M. de Medina-Redondo, Y. 
Arnaiz-Pita, C. Clavaud, T. Fontaine, F. del Rey, J. P. Latge, C. R. 
Vazquez de Aldana, PLoS One 2010, 5, e14046. 
[7] R. Hurtado-Guerrero, A. W. Schuettelkopf, I. Mouyna, A. F. M. Ibrahim, 
S. Shepherd, T. Fontaine, J.-P. Latge, D. M. F. van Aalten, J. Biol. 
Chem. 2009, 284, 8461-8469. 
[8] L. Raich, V. Borodkin, W. Fang, J. Castro-Lopez, D. M. F. van Aalten, R. 
Hurtado-Guerrero, C. Rovira, J. Am. Chem. Soc. 2016, 138, 3325-3332. 
[9] I. Delso, J. Valero-González, E. Marca, T. Tejero, R. Hurtado-Guerrero, 
P. Merino, Chem. Biol. Drug Design 2016, 87, 163-170. 
7 12
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
COMMUNICATION          
 
 
 
 
[10] J. L. Asensio, A. Arda, F. J. Canada, J. Jimenez-Barbero, Acc. Chem. 
Res. 2013, 46, 946-954. 
[11] M. Kumar, P. V. Balaji, J. Mol. Model. 2014, 20, 2136. 
[12] C. D. Hein, X. M. Liu, D. Wang, Pharm. Res. 2008, 25, 2216-2230. 
[13] V. K. Tiwari, B. B. Mishra, K. B. Mishra, N. Mishra, A. S. Singh, X. Chen, 
Chem. Rev. 2016, 116, 3086-3240. 
[14] T. Tejero, S. García-Viñuales, I. Delso, P. Merino, Synthesis 2016, 48, 
3339-3351. 
[15] C. R. Martinez, B. L. Iverson, Chemical Science 2012, 3, 2191-2201. 
[16] S. Yamada, N. Yamamoto, E. Takamori, The Journal of Organic 
Chemistry 2016, 81, 11819-11830. 
[17] R. Anjana, M. K. Vaishnavi, D. Sherlin, S. P. Kumar, K. Naveen, P. S. 
Kanth, K. Sekar, Bioinformation 2012, 8, 1220-1224. 
[18] (a) E. R. Johnson, S. Keinan, P. Mori-Sanchez, J. Contreras-Garcia, A. 
J. Cohen, W. Yang, J. Am. Chem. Soc. 2010, 132, 6498-6506. (b) J. R. 
Lane, J. Contreras-Garcia, J.-P. Piquemal, B. J. Miller, H. G. 
Kjaergaard, J. Chem. Theory Comput. 2013, 9, 3263-3266. 
[19] The biological evaluation of 12 towards AfGel4 was carried out through 
a competition assay using a mixture of G14- and G15-
laminooligosaccharides, where their disappearance was quantified by 
RP-UPLC.  
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
COMMUNICATION          
 
 
 
 
 
 
Entry for the Table of Contents (Please choose one layout) 
 
 
COMMUNICATION 
X-ray crystallography revealed the 
importance of triazole π,π- and 
azinium-π (cation-π) interactions in 
the design of low μM ligands for 
fungal transglycosylases  
 
 
 I. Delso,* J. Valero-Gonzalez, F. 
Gomollón-Bel, J. Castro-López, W. 
Fang,  I. Navratilova, D. M.F. van 
Aalten, T. Tejero, P. Merino,* and R. 
Hurtado-Guerrero* 
Page No. – Page No. 
Exploiting Azinium-π  Interactions  in  
Structure-guided Discovery of 
Glucan-remodelling Enzymes 
Glycomimetic Compounds. 
 
  
 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
